tiprankstipranks
Trending News
More News >
Ivy Cosmetics Corporation (JP:4918)
:4918
Japanese Market

Ivy Cosmetics Corporation (4918) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4918

Ivy Cosmetics Corporation

(4918)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
¥444.00
▲(30.97% Upside)
Action:DowngradedDate:10/31/25
Ivy Cosmetics Corporation's stock score is primarily driven by its strong financial performance and attractive valuation. The company's solid recovery trajectory and robust cash flow generation enhance its financial stability. However, technical indicators suggest bearish momentum, which may pose short-term risks. The low P/E ratio highlights potential undervaluation, making it an attractive investment opportunity despite the technical weaknesses.
Positive Factors
Strong balance sheet / low leverage
A high equity ratio and very low debt-to-equity provide durable financial resilience, reducing default risk and interest burden. This balance-sheet strength supports capital allocation flexibility for product investment, M&A or downturns without pressuring cash flow or requiring emergency financing.
Robust cash generation and conversion
Consistent free cash flow growth and exceptional cash conversion signal sustainable internal funding for capex, working capital and strategic initiatives. Strong OCF relative to earnings reduces reliance on external capital and underpins long-term investment and balance-sheet improvement.
High gross margins & recovering operating margins
Very high gross margins indicate structural product-level pricing power or low variable costs, while a return to positive EBIT shows operational leverage. Together these support sustainable profit potential if SG&A and non-operating costs remain controlled over the medium term.
Negative Factors
Very low net profit margin and modest ROE
Despite strong gross margins and cash generation, near-zero net margin and weak ROE show limited shareholder returns and poor bottom-line conversion. Persistent low net profitability constrains reinvestment, dividend potential and the ability to absorb shocks or fund growth from earnings.
Declining EBITDA margin from higher non-operational costs
A falling EBITDA margin driven by non-operational or recurring extra costs erodes core earnings quality. If these expenses persist, they can offset operational improvements, reduce free cash flow upside, and limit the firm’s capacity to scale profitably over the medium term.
Moderate and inconsistent revenue growth
Revenue recovery is moderate after prior declines, implying growth remains uneven. Without stronger, sustained top-line expansion, fixed-cost leverage and margin improvements may be insufficient to materially raise profitability or returns, leaving strategy vulnerable to competition and market saturation.

Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)

Ivy Cosmetics Corporation Business Overview & Revenue Model

Company DescriptionIvy Cosmetics Corporation manufactures and sells cosmetics and beauty supplement products. The company offers penetrating beauty liquid, lotion/emulsion/cream, and cleansing/face wash products. It also offers optional care, makeup, hair care, and body care products; health food/equipment, UV protection, and men's cosmetics. The company was formerly known as Shirogane Corporation and changed its name to Ivy Cosmetics Corporation in October 1977. Ivy Cosmetics Corporation was incorporated in 1975 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyIvy Cosmetics Corporation generates revenue primarily through the sale of its cosmetic products across multiple channels, including retail, e-commerce, and direct-to-consumer platforms. The company has established key partnerships with major beauty retailers and online marketplaces, allowing it to reach a wide audience. Additionally, Ivy Cosmetics invests in brand collaborations and influencer marketing to boost product visibility and sales. Its revenue model also includes subscription services for exclusive product launches, which provide a steady stream of income. Seasonal promotions and loyal customer programs further enhance customer retention and drive repeat purchases, contributing significantly to the company's overall earnings.

Ivy Cosmetics Corporation Financial Statement Overview

Summary
Ivy Cosmetics Corporation shows a solid recovery with revenue growth and improved operational metrics. The balance sheet is strong with low leverage, enhancing financial stability. Cash flow generation is robust, supporting liquidity and operational needs. However, challenges remain in consistently translating revenue growth into higher profitability.
Income Statement
65
Positive
Ivy Cosmetics Corporation has experienced a recent recovery in revenue growth, with a 7.95% increase from 2024 to 2025, following a decline in prior years. Gross profit margin remains strong at 70.5% in 2025, indicating efficient cost control. However, the net profit margin is low at 1.47%, reflecting challenges in converting revenue into profit. The EBIT margin improved significantly to 14.42% in 2025 from previous negative margins, showing operational improvements, though EBITDA margin has declined, indicating higher non-operational expenses.
Balance Sheet
72
Positive
The balance sheet shows a strong equity position with an equity ratio of 69.19% in 2025, indicating financial stability. The debt-to-equity ratio has improved to 0.14, suggesting effective debt management. Return on equity, however, is modest at 1.74%, indicating limited profitability relative to shareholder investments. The overall leverage is low, reducing financial risk.
Cash Flow
78
Positive
Cash flow analysis reveals robust free cash flow growth of 3.91% from 2024 to 2025, indicating strong cash generation capability. The operating cash flow to net income ratio is high at 10.37, reflecting efficient cash operations. The company's ability to convert net income into free cash flow is impressive, with a ratio of 9.87, highlighting effective capital expenditure management.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.93B2.71B2.94B3.53B3.43B
Gross Profit2.07B1.91B2.11B2.42B2.14B
EBITDA20.62M242.60M-33.16M185.13M255.05M
Net Income43.01M160.31M-384.61M40.38M-23.23M
Balance Sheet
Total Assets3.57B3.57B3.85B4.35B4.72B
Cash, Cash Equivalents and Short-Term Investments577.94M208.73M247.67M129.38M113.43M
Total Debt339.85M451.69M1.05B1.18B1.79B
Total Liabilities1.10B1.33B1.87B2.09B3.20B
Stockholders Equity2.47B2.24B1.98B2.27B1.51B
Cash Flow
Free Cash Flow424.68M408.70M243.33M-160.58M374.53M
Operating Cash Flow445.94M453.06M278.59M-107.06M427.02M
Investing Cash Flow-18.43M7.30M-29.30M63.30M330.37M
Financing Cash Flow-58.27M-499.31M-131.00M59.71M-693.39M

Ivy Cosmetics Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price339.00
Price Trends
50DMA
378.70
Positive
100DMA
356.94
Positive
200DMA
341.46
Positive
Market Momentum
MACD
9.94
Positive
RSI
53.88
Neutral
STOCH
12.99
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Positive. The current price of 339 is below the 20-day moving average (MA) of 401.05, below the 50-day MA of 378.70, and below the 200-day MA of 341.46, indicating a bullish trend. The MACD of 9.94 indicates Positive momentum. The RSI at 53.88 is Neutral, neither overbought nor oversold. The STOCH value of 12.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4918.

Ivy Cosmetics Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
¥2.29B6.5912.96%
68
Neutral
¥2.40B10.171.72%-6.06%-97.12%
63
Neutral
¥6.84B10.152.38%-0.79%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
¥6.55B47.901.59%-9.99%-35.06%
58
Neutral
¥5.82B24.361.68%8.46%
52
Neutral
¥6.75B14.52-19.42%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4918
Ivy Cosmetics Corporation
403.00
160.00
65.84%
JP:4920
Nippon Shikizai, Inc.
1,146.00
30.11
2.70%
JP:4925
HABA Laboratories, Inc.
1,810.00
50.77
2.89%
JP:4926
C'BON COSMETICS Co., Ltd.
1,359.00
206.37
17.90%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
815.00
-15.83
-1.91%
JP:4934
Premier Anti-Aging Co., Ltd.
774.00
-93.00
-10.73%

Ivy Cosmetics Corporation Corporate Events

Ivy Cosmetics Swings Back to Profit on Higher Margins Despite Softer Sales
Feb 10, 2026

Ivy Cosmetics reported net sales of ¥1.70 billion for the quarter ended December 2025, a slight 1.8% decline from a year earlier, but significantly improved profitability, with operating profit nearly doubling to ¥33 million and ordinary profit also doubling to ¥30 million. The company moved from a large loss to a modest profit of ¥13 million versus a ¥333 million loss a year earlier, strengthened its financial position with a higher capital adequacy ratio of 75.0%, and maintained a zero dividend for the second quarter, signaling a continued focus on preserving capital and rebuilding earnings after prior losses.

The most recent analyst rating on (JP:4918) stock is a Hold with a Yen414.00 price target. To see the full list of analyst forecasts on Ivy Cosmetics Corporation stock, see the JP:4918 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025